Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yujing Li

3PUBLICATIONS

27CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 22, 2025

Reprogramming intratumoral T<sub>reg</sub> cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy.

Yujing Li, Naresh Singh, Chuanpeng Dong

|Jun 24, 2022

FOXP3 exon 2 controls T<sub>reg</sub> stability and autoimmunity.

Jianguang Du, Qun Wang, Shuangshuang Yang

|Feb 11, 2021

Targeted immunotherapy for HER2-low breast cancer with 17p loss.

Yujing Li, Yifan Sun, Michael Kulke

Pageof 1

Frequent Collaborators

3 joint publications

Xiongbin Lu

2 joint publications

Xinna Zhang

2 joint publications

Jianguang Du

2 joint publications

Baohua Zhou

1 joint publications

Michael Kulke

1 joint publications

Torsten Hechler

1 joint publications

Kevin Van der Jeught

1 joint publications

Bin He

1 joint publications

Shuangshuang Yang

1 joint publications

Si Chen

Frequent Collaborators

3 joint publications

Xiongbin Lu

2 joint publications

Xinna Zhang

2 joint publications

Jianguang Du

2 joint publications

Baohua Zhou

Top Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on : Nov 11, 2016

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Naïve CD4<sup>+</sup> T Cells Using a TGF-β-containing Protocol

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Naïve CD4<sup>+</sup> T Cells Using a TGF-β-containing Protocol

Published on : Dec 30, 2016

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

See more related videos

Top Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on : Nov 11, 2016

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Naïve CD4<sup>+</sup> T Cells Using a TGF-β-containing Protocol

<em>In Vitro</em> Differentiation of Human CD4<sup>+</sup>FOXP3<sup>+</sup> Induced Regulatory T Cells (iTregs) from Naïve CD4<sup>+</sup> T Cells Using a TGF-β-containing Protocol

Published on : Dec 30, 2016

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

See more related videos